Finance

Lists
Q3 2026 earnings • in 3 days
See details
REF:NYSE
Reformation Inc.
$15.90
+0.51%
(+0.080) 1D
$16.37
+2.96% (+0.47)
After hours
Closed: Nov 2, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REF...
Open
$16.07
High
$16.38
Low
$15.60
Mkt. cap
939.36M
Avg. vol.
440.95K
Volume
294.66K
52-wk high
$17.26
52-wk low
$11.85
No. of employees
1K
Open
$16.07
High
$16.38
Low
$15.60
Mkt. cap
939.36M
Avg. vol.
440.95K
Volume
294.66K
52-wk high
$17.26
52-wk low
$11.85
No. of employees
1K
News stories
From web sources and news partners
About Reformation Inc.
CEO-
Employees1.35K
Founded2009
HeadquartersVernon, California, United States
SectorConsumer
Websitethereformation.com
Analyst ratings
Based on 9 analysts giving stock ratings to REF in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for REF in the last 3 months.
Highest
Current $15.90
$21.00 (+32.08%)
Average
$19.25 (+21.07%)
Lowest
$16.00 (+0.63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dana Telsey
Telsey Advisory
Buy
Maintained
$20.00
+25.8%
10/30/2026
Irene Nattel
RBC Capital
Buy
Reiterated
$18.00
+13.2%
10/26/2026
Janine Stichter
BTIG
Buy
Reiterated
$20.00
+25.8%
09/11/2026
Paul Lejuez
Citi
Buy
Reiterated
$20.00
+25.8%
09/11/2026
Dylan Carden
William Blair
Buy
Maintained
-
-
09/11/2026
Simeon Siegel
Guggenheim
Buy
Initiated
$20.00
+25.8%
08/24/2026
Alexandra Straton
Morgan Stanley
Hold
Initiated
$16.00
+0.6%
08/24/2026
Mark Altschwager
Robert W. Baird
Buy
Initiated
$19.00
+19.5%
08/24/2026
Unknown Analyst
RBC Capital
Buy
Initiated
$18.00
+13.2%
08/24/2026
Matthew Boss
J.P. Morgan
Buy
Initiated
$21.00
+32.1%
08/24/2026
Next call in 3 days
Thu, Nov 5, 5:00 PM
Fiscal period
Q3 2026
- / $0.11
Revenue / Est. (USD)
- / 169.72M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
86.09M
125.07M
112.30M
155.23M
Cost of goods sold
34.21M
44.51M
33.30M
51.76M
Cost of revenue
34.21M
44.51M
33.30M
51.76M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.58M
67.09M
91.39M
84.28M
Operating expense
55.58M
67.09M
91.39M
84.28M
Total operating expenses
89.80M
111.59M
124.69M
136.04M
Operating income
-3.71M
13.48M
-12.39M
19.19M
Other non operating income
-73.00K
308.00K
-255.00K
1.44M
EBT including unusual items
-7.48M
9.28M
-16.05M
17.10M
EBT excluding unusual items
-7.28M
10.17M
-15.60M
17.27M
Income tax expense
-1.93M
2.36M
-3.90M
4.70M
Effective tax rate
25.76%
25.44%
24.33%
27.46%
Other operating expenses
-
-
-
-
Net income
-5.55M
6.92M
-12.15M
12.41M
Net profit margin
-6.45%
5.53%
-10.82%
7.99%
Earnings per share
-
-
-
0.24
Interest and investment income
655.00K
414.00K
313.00K
185.00K
Interest expense
-4.15M
-4.04M
-3.27M
-3.54M
Net interest expenses
-3.50M
-3.62M
-2.96M
-3.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-846.00K
16.50M
-8.23M
23.43M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps